TPP-resveratrol
TPP-resveratrol is a conjugate of Resveratrol (HY-16561) and triphenylphosphine (TPP) with anticancer activity. TPP-resveratrol increases the potency of Resveratrol through mitochondrial-targeted delivery and induces mitochondria-mediated apoptosis[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tpp-resveratrol.html
Purity
99.76
Solubility
DMSO : 116.67 mg/mL (ultrasonic)
Smiles
O=C(CCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)OC4=CC(O)=CC(/C=C/C5=CC=C(C=C5)O)=C4.[Br-]
Molecular Formula
C36H32BrO4P
Molecular Weight
639.51
References & Citations
[1]Jiang L, et al. The anti-cancer effects of mitochondrial-targeted triphenylphosphonium–resveratrol conjugate on breast cancer cells[J]. Pharmaceuticals, 2022, 15 (10) : 1271.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2118908 1.0 µg DNA
SENP6 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
GTR15269506 1 Vial
Lentiviral mouse Pfn3 shRNA (UAS) - Lentiviral mouse Pfn3 shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details 
K0676903 1.0 µg DNA
ELP3 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
LV709104 1.0 µg DNA
CXorf57 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details